NICE guidance on aflibercept for treatment of metastatic colorectal cancer

被引：0
|
作者：
Elsada, Ahmed [1 ]
George, Elisabeth [1 ]
Adler, Amanda [1 ]
机构：
[1] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 06期
关键词：
D O I：
10.1016/S1470-2045(14)70133-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：561 / 562
页数：2
相关论文
共 50 条
  • [21] Role of aflibercept in the treatment of advanced colorectal cancer
    Delgado, Marian Gil
    Delgado, Francois Michel
    Khayat, David
    COLORECTAL CANCER, 2014, 3 (01) : 27 - 40
  • [22] Experience with Aflibercept as a second line chemotherapy in metastatic colorectal cancer
    Gonzalez-Flores, E.
    Gonzalez-Astorga, B.
    Urena M, T. Delgado
    Conde, V.
    Sanchez-Toro, C.
    Legeren Alvarez, M.
    Villaescusa, A.
    Galvez Montosa, F.
    Garcia-Garcia, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 41 - 42
  • [23] GUIDELINES Diagnosis and management of colorectal cancer: summary of NICE guidance
    Poston, G. J.
    Tait, D.
    O'Connell, S.
    Bennett, A.
    Berendse, S.
    BRITISH MEDICAL JOURNAL, 2011, 343 : 1010 - 1012
  • [24] NICE guidance on bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
    Umeweni, Nwamaka
    Nolan, Kay
    Knight, Helen
    Clark, Peter
    LANCET ONCOLOGY, 2012, 13 (10): : 977 - 978
  • [25] Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice
    Tomas Buchler
    Igor Kiss
    Jana Hornova
    Ondrej Fiala
    Marketa Wiesnerova
    Michal Svoboda
    Jiri Silar
    Katerina Kopeckova
    Alexandr Poprach
    Jindrich Finek
    Lubos Petruzelka
    Bohuslav Melichar
    Targeted Oncology, 2020, 15 : 193 - 201
  • [26] Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
    Mario Scartozzi
    Loic Vincent
    Marielle Chiron
    Stefano Cascinu
    Targeted Oncology, 2016, 11 : 489 - 500
  • [27] Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
    Scartozzi, Mario
    Vincent, Loic
    Chiron, Marielle
    Cascinu, Stefano
    TARGETED ONCOLOGY, 2016, 11 (04) : 489 - 500
  • [28] Treatment of metastatic colorectal Cancer Aflibercept/FOLFIRI can be widely used in the second Therapy Line
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (06) : 358 - 358
  • [29] Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice
    Buchler, Tomas
    Kiss, Igor
    Hornova, Jana
    Fiala, Ondrej
    Wiesnerova, Marketa
    Svoboda, Michal
    Silar, Jiri
    Kopeckova, Katerina
    Poprach, Alexandr
    Finek, Jindrich
    Petruzelka, Lubos
    Melichar, Bohuslav
    TARGETED ONCOLOGY, 2020, 15 (02) : 193 - 201
  • [30] NICE guidance on enzalutamide for metastatic hormone-relapsed prostate cancer
    Elsada, Ahmed
    Pearce, Fiona
    George, Elisabeth
    Adler, Amanda
    LANCET ONCOLOGY, 2014, 15 (10): : 1058 - 1059
12345